Membranous nephropathy (MN) is a leading cause of nephrotic syndrome in adults, with highly variable clinical outcomes ranging from spontaneous remission to progression to chronic kidney disease. Initial clinical response is a reliable predictor of long-term course. We evaluated longitudinal changes in proteinuria, serum albumin, renal function, and treatment response over an 18-month follow-up period in patients with biopsy-proven MN enrolled in a pan-India glomerulonephritis (GN) registry.
Yadav et al. (Wed,) studied this question.